US Stock MarketDetailed Quotes
TRAW Traws Pharma
- 0.430
- 0.000-0.02%
Close Jul 29 16:00 ET
- 0.410
- -0.020-4.63%
Post 16:18 ET
10.88MMarket Cap-499P/E (TTM)
0.444High0.410Low83.77KVolume0.444Open0.430Pre Close35.40KTurnover0.37%Turnover RatioLossP/E (Static)25.31MShares1.10052wk High1.81P/B9.65MFloat Cap0.33352wk Low--Dividend TTM22.45MShs Float70042.500Historical High--Div YieldTTM7.91%Amplitude0.333Historical Low0.422Avg Price1Lot Size
Traws Pharma Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 2.62%-4.42M | -10.05%-17.93M | -14.06%-4.43M | -14.59%-4.47M | -6.55%-4.49M | -5.75%-4.54M | 16.39%-16.29M | 8.93%-3.88M | 8.60%-3.9M | 2.16%-4.21M |
| Net income from continuing operations | 13.71%-4.98M | 0.08%-18.95M | 22.80%-4.18M | 12.21%-4.74M | -5.62%-4.25M | -40.10%-5.78M | -17.33%-18.96M | -44.00%-5.42M | -56.33%-5.4M | 4.89%-4.02M |
| Depreciation and amortization | 33.33%4K | 14.29%16K | 0.00%4K | 66.67%5K | 0.00%4K | 0.00%3K | 0.00%14K | 0.00%4K | 0.00%3K | 0.00%4K |
| Change In working capital | -75.14%222K | -120.28%-301K | -148.42%-582K | -107.98%-95K | -18.85%-517K | 288.79%893K | 141.30%1.48M | 256.92%1.2M | 349.48%1.19M | -251.57%-435K |
| -Change in receivables | --0 | 1,200.00%11K | --0 | ---1K | --0 | 1,100.00%12K | -111.11%-1K | -200.00%-1K | --0 | -109.09%-1K |
| -Change in prepaid assets | 131.54%76K | -450.22%-1.26M | -113.11%-72K | -388.67%-1.05M | 111.02%98K | 3.98%-241K | -143.21%-229K | 62.91%549K | 602.78%362K | -692.67%-889K |
| -Change in payables and accrued expense | -82.85%202K | -39.20%1.17M | -163.94%-454K | 15.07%1.01M | -208.98%-558K | 805.39%1.18M | 149.44%1.93M | 178.02%710K | 284.81%876K | 195.95%512K |
| -Change in other current assets | ---- | --0 | --0 | ---- | ---- | ---- | --9K | --0 | ---- | ---- |
| -Change in other working capital | 0.00%-56K | 0.00%-226K | 0.00%-56K | 0.00%-57K | 0.00%-57K | 0.00%-56K | 0.00%-226K | 0.00%-56K | 0.00%-57K | 0.00%-57K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 2.62%-4.42M | -10.05%-17.93M | -14.06%-4.43M | -14.59%-4.47M | -6.55%-4.49M | -5.75%-4.54M | 16.39%-16.29M | 8.93%-3.88M | 8.60%-3.9M | 2.16%-4.21M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -14K | 0 | 0 | 0 | ||||||
| Net PPE purchase and sale | ---- | ---14K | --0 | ---- | ---- | ---- | --0 | --0 | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | ---- | ---14K | --0 | ---- | ---- | ---- | --0 | --0 | ---- | ---- |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | ||||||||||
| Cash from discontinued financing activities | ||||||||||
| Net cash flow | ||||||||||
| Beginning cash position | -46.28%20.82M | -29.62%38.76M | -40.76%25.24M | -36.11%29.73M | -32.59%34.22M | -29.62%38.76M | 189.46%55.07M | -28.23%42.61M | 6.46%46.53M | 5.75%50.77M |
| Current changes in cash | 2.62%-4.42M | -10.14%-17.95M | -14.06%-4.43M | -14.95%-4.48M | -6.55%-4.49M | -5.75%-4.54M | -145.17%-16.29M | 9.67%-3.88M | -124.88%-3.9M | 2.00%-4.21M |
| Effect of exchange rate changes | -216.67%-7K | 152.63%10K | -75.00%7K | 90.00%-2K | 95.00%-1K | 185.71%6K | 32.14%-19K | 450.00%28K | -150.00%-20K | -600.00%-20K |
| End cash Position | -52.10%16.39M | -46.28%20.82M | -46.28%20.82M | -40.76%25.24M | -36.11%29.73M | -32.59%34.22M | -29.62%38.76M | -29.62%38.76M | -28.23%42.61M | 6.46%46.53M |
| Free cash flow | 2.62%-4.42M | -10.14%-17.95M | -14.06%-4.43M | -14.95%-4.48M | -6.55%-4.49M | -5.75%-4.54M | 16.39%-16.29M | 8.93%-3.88M | 8.60%-3.9M | 2.16%-4.21M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg